These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31127490)

  • 1. Post-Basal Insulin Intensification and Healthcare Resource Use in Type 2 Diabetes: A Web-Based Physician Survey in the United States and United Kingdom.
    Brod M; Basse A; Markert M; Pfeiffer KM
    Diabetes Ther; 2019 Aug; 10(4):1323-1336. PubMed ID: 31127490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients.
    Pfeiffer KM; Basse A; Lee XY; Waldman LT
    Diabetes Ther; 2018 Oct; 9(5):1931-1944. PubMed ID: 30120755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.
    Khunti K; Nikolajsen A; Thorsted BL; Andersen M; Davies MJ; Paul SK
    Diabetes Obes Metab; 2016 Apr; 18(4):401-9. PubMed ID: 26743666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes.
    Mocarski M; Yeaw J; Divino V; DeKoven M; Guerrero G; Langer J; Thorsted BL
    J Manag Care Spec Pharm; 2018 Apr; 24(4):390-400. PubMed ID: 29406841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMPARING CLINICAL OUTCOMES AND COSTS FOR DIFFERENT TREATMENT INTENSIFICATION APPROACHES IN PATIENTS WITH TYPE 2 DIABETES UNCONTROLLED ON BASAL INSULIN: ADDING GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS VERSUS ADDING RAPID-ACTING INSULIN OR INCREASING BASAL INSULIN DOSE.
    Levin P; Fan T; Song X; Nero D; Davis B; Chu BC
    Endocr Pract; 2017 Nov; 23(11):1316-1324. PubMed ID: 28816532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin.
    Blonde L; Raccah D; Lew E; Meyers J; Nikonova E; Ajmera M; Davis KL; Bertolini M; Guerci B
    Diabetes Ther; 2018 Jun; 9(3):1169-1184. PubMed ID: 29675797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of delaying treatment intensification with a glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes uncontrolled on basal insulin: A longitudinal study of a US administrative claims database.
    Tong L; Pan C; Wang H; Bertolini M; Lew E; Meneghini LF
    Diabetes Obes Metab; 2018 Apr; 20(4):831-839. PubMed ID: 29119712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies.
    Fadini GP; Disoteo O; Candido R; Di Bartolo P; Laviola L; Consoli A
    Diabetes Ther; 2021 Mar; 12(3):781-800. PubMed ID: 33550569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal-Bolus Insulin in Type 2 Diabetes.
    Lingvay I; Catarig AM; Lawson J; Chubb B; Gorst-Rasmussen A; Evans LM
    Diabetes Ther; 2023 Jan; 14(1):123-137. PubMed ID: 36434159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of intensification therapies in Danes with Type 2 diabetes who use basal insulin: a population-based study.
    Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabet Med; 2017 Feb; 34(2):213-222. PubMed ID: 27279380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes.
    Wu T; Betty B; Downie M; Khanolkar M; Kilov G; Orr-Walker B; Senator G; Fulcher G
    Diabetes Ther; 2015 Sep; 6(3):273-87. PubMed ID: 26104878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal-Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes.
    Linjawi S; Lee BW; Tabak Ö; Lövdahl S; Werther S; Abusnana S
    Diabetes Ther; 2018 Feb; 9(1):1-11. PubMed ID: 29129018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal Insulin Intensification in Patients with Type 2 Diabetes: A Review.
    Meece J
    Diabetes Ther; 2018 Jun; 9(3):877-890. PubMed ID: 29574634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial glucose and healthcare resource use: a cross-sectional survey of adults with diabetes treated with basal-bolus insulin.
    Pfeiffer KM; Sandberg A; Nikolajsen A; Brod M
    J Med Econ; 2018 Jan; 21(1):66-73. PubMed ID: 28875766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study.
    Miyoshi H; Matsuhisa M; Yabe D; Takahashi Y; Morimoto Y; Terauchi Y
    Diabetes Ther; 2023 Apr; 14(4):671-689. PubMed ID: 36809494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation and Intensification Strategies in Type 2 Diabetes Management: A Comparison of Basal Plus and Premix Regimens.
    Downie M; Kilov G; Wong J
    Diabetes Ther; 2016 Dec; 7(4):641-657. PubMed ID: 27658921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of once daily GLP-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway.
    Huetson P; Palmer JL; Levorsen A; Fournier M; Germe M; McLeod E
    J Med Econ; 2015; 18(8):573-85. PubMed ID: 25853868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized intensification of insulin therapy in type 2 diabetes - does a basal-bolus regimen suit all patients?
    Giugliano D; Sieradzki J; Stefanski A; Gentilella R
    Curr Med Res Opin; 2016 Aug; 32(8):1425-34. PubMed ID: 27126277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding suboptimal insulin use in type 1 and 2 diabetes: a cross-sectional survey of healthcare providers who treat people with diabetes.
    Newson RS; Spaepen E; Liao B; Bower J; Bhattacharya I; Artime E; Polonsky W
    BMC Prim Care; 2024 Apr; 25(1):124. PubMed ID: 38649812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes.
    Falcetta P; Nicolì F; Citro F; Ciccarone A; Garofolo M; Del Prato S; Bianchi C
    Acta Diabetol; 2023 Jan; 60(1):53-60. PubMed ID: 36166172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.